Giving value to its excellent qualities and being organized to face, in a competitive manner the national and international market, in the past years the Fondazione has guided the development of some successful spin-offs in various sectors.
The skills, operational procedures, good medical, assistance and management practices created by the Fondazione become development models and permit the Gemelli to “leave” the historical Roman campus and create, with its know-how, other health experiences. Paving the way for possible relations and collaboration networking that benefits an audience that becomes increasingly bigger in territory and communities, the Gemelli spreads a culture of treatment that is a benchmark for others.
Mater Olbia Hospital
The first out-patient services started in December 2018 and from June 2019 the Mater Olbia Hospital has been fully operational, with its new hospital facilities located in Northern Sardinia which guarantee an excellent medical-health center to the entire island.
The Fondazione Policlinico Universitario Agostino Gemelli IRCCS, a minority shareholder of Mater Olbia SpA and scientific partner of the Qatar Foundation Endowment, owner of the facilities, manages the medical activities of the new hospital, bringing its know-how, professionalism and skills in order to manage a difficult and complex health system and hospital services in an area where until now the demand for treatment has been higher than the offer.
The Mater Olbia offers a wide range of services, among which specialized neurological, orthopedic and pediatric services, as well as a state-of-the-art radiation therapy center.
The facility has 250 hospital beds, of which 200 are for Regional Health System assistance and 50 are for private practice assistance. Diagnostic services, such as the analysis Laboratory, Image Diagnosis and the Specialized out-patient service have also been accredited.
Through a big data platform, created in collaboration with General Electric, Mater Olbia is able to provide more effective, quicker and targeted treatments and it can also be a precious reference point for the Sardinian hospital network.
Thanks to the strong relationship with the School of Medicine and Surgery at the Università Cattolica, the Fondazione Policlinico Universitario A. Gemelli IRCCS represents the perfect combination of scientific and technical skills, sensitivity and human ethics, that make it an excellent hospital, both in terms of quality of treatment and of accessibility for the entire community: a hospital that truly takes care of people, not focussing just on the treatment of illnesses.
The hospital’s organizational chart includes 500 internal employees and provides work to about 400 external collaborators.
Visit the site: GO
Since July 2018, Gemelli Molise – a hospital that was promoted in 2002 by the Università Cattolica del Sacro Cuore – was integrated, in all respects, into the scope of medical-assistance services of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
With its 130 hospital beds and the recognized quality of specializations in the fields of cancer treatment and cardiovascular illnesses, Gemelli Molise of Campobasso is an important health reference point for all of South Eastern Italy: it provides excellent medical-assistance services in addition to hosting university courses in Nursing, Medical Radiology Image Techniques, Radiation therapy and Physiotherapy from the Università Cattolica del Sacro Cuore of Rome and promotes refresher courses, conventions and training events for health sector professionals.
This is a step which allows Gemelli Molise to further improve the quality of services offered in the Molise region and in the bordering regions, in addition to being able to achieve important collaborations by sharing common services combining two fundamental objectives, greater treatment effectiveness and greater management efficiency.
Since 2008 it has received the recognition “Ospedale a misura di donna” (Hospital fit for women) from the national Monitoring Center on women’s health (O.N.Da). In 2016, the quality of the services were also certified by the Piano Nazionale Esiti, the tool with which the National Agency for the Regional health services (AGE.NA.S) develops the evaluation of health activity results for the Italian Health Service.
With about 1,000 scientific publications, Gemelli Molise since its beginning, has been committed to scientific research activities, particularly in the areas of cancer treatment and cardiovascular illnesses, for which the medical practice is enhanced in order to ensure a patient-oriented management and the transfer of information directly to the patient’s hospital bed.
There are about 100 research projects with the most prestigious international institutes.
Visit the site: GO
Clinical Trial Center
The Clinical Trial Center SpA is a company owned by the Fondazione Policlinico Gemelli and partially owned by Principia SGR, and during its first year of activity it achieved important results regarding profit medical experiments.
The contacts established with pharmaceutical entities, along with the strong involvement of the Fondazione’s researchers, have led to an increase in the amount of new studies launched and, consequently, also in the amount of the Ethics Committee support activities: in 2018 there was an impressive total of 216 analyzed cases.
The appeal of new studies, in addition to the significant performance improvement, with particular consideration to the medical areas tied to children’s and women’s health, gastroenterology, neuroscience, medical oncology and to hematology, have brought an increase in revenue, compared to the previous year, for an overall amount of more than 6 million Euros in 2018.
Such results, achieved thanks to the contribution of researchers and of all the facilities within the Fondazione, provide a picture of the continuously growing attention given by the Fondazione and all its professionals towards new medical research frontiers, taking into account also the recent recognition as IRCCS, and will be the basis for the development of new collaborations with pharmaceutical and health entities for the years to come.
Visit the site: GO
XBioGem is a company created from the partnership between the Policlinico Universitario A. Gemelli IRCCS and BioRep, a Gruppo Sapio company specialized in cryopreservation services.
It provides laboratory services and storage of biological material services to public and private research institutes, guaranteeing the highest levels of quality and safety.
The high quality specialization, the state-of-the-art technologies that the company offers and the standardization of the most advanced techniques for material sampling make XBioGem the benchmark provider of biological samples and of high quality laboratory services, able to create and provide useful data for successful scientific research.
In fact, one of the company’s objectives is to create and manage a biobank aimed at collecting, storing and distributing human biological samples that can support research activities in the academic field, in addition to developing collaborations with the pharmaceutical industry, biotech industry and public and private Medical centers and laboratories.
Specifically, XBioGem is specialized in preparing cell lines, extracting nucleic acids, long-term storing of various samples of biological material in liquid nitrogen (-196°C), in nitrogen vapors (-156°C) and in mechanical freezers (-80°C).
Using a management software platform of the reliable sample guarantees traceability during all the procedural and storage phases allowing it to be identified, registered and filed through a unique bar code. In addition, it offers high quality molecular biology services (among which the purification of nucleic acids, sequencing, genotyping) and cellular biology services (isolates, captures, preserves and distributes cellular lines and DNA of these by-products.
Go to the site: GO
Gemelli Health System (GHS)
The Gemelli Health System (GHS) is a company created within the Fondazione Policlinico Universitario Agostino Gemelli and deals with personalized therapies obtained thanks to mixtures of micronutrients.
GHS is committed to implementing treatments with nutrient mixtures for rare diseases and specific patients, with approaches increasingly personalized that enhance the Gemelli’s commitment, closing the gaps in the offer of micronutrients and macronutrients.
The idea of a company focused on Alimenti a Fini Medici Speciali (AFMS) (Special Medical Foods) came from the implementation, put into effect by the Policlinico Gemelli experts, of a European guideline named ERAS, created with the intent to improve the patient’s operative and post-operative care.
All doctors at the Gemelli take part in this project and have put into practice the ERAS guideline through the use of nutrient mixtures (NutriCatt) in order to make a line of Special Medical Foods available, that is capable of responding to the specific wellness request, that doctors receive from patients and their families on a daily basis.
Each GHS product is created by choosing active principles and nutrients that have been carefully selected, containing absolutely no pollutants nor impurities, in order to guarantee a final product that offers the best quality to each patient, according to his or her individual needs.
GHS will make a toll-free number available specifically to provide information and will make its products available to patients all over Italy through a logistic network and a certified productive supply chain.
Visit the site: GO
Gemelli a Casa
At the end of 2018, the second Gemelli a Casa S.p.A (GAC) was created, which is the result of the collaboration of the Fondazione (50%) and of OSA Cooperativa sociale (50%), one of the main Italian providers in the integrated home care field.
The goal is to offer highly qualified socio-medical services according to an overall responsibility-oriented standard and integrated directly at the patient’s home. The multidisciplinary team will deal with evaluating the patient’s complex needs with the objective of identifying an appropriate assistance plan and monitoring it over the years; this service is also possible for hospitalized patients in order to guarantee treatment continuation and assumption of responsibility.